Volume 4 Supplement 2

Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Meeting abstracts

Publication of this supplement was made possible with support from the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health.

11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research. Go to conference site.

Bethesda, MD, USA6-7 October 2008

Concatenated PDF 4S2

Page 2 of 2

MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival

Authors: E Forte and MA Luftig

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P26

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma

Authors: MS McGrath, M Salemi, R Grey, D Galligan and SL Lamers

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P27

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Genetic resistance to GAHV-2 induced lymphoma in the chicken model

Authors: MM Miller, Y Wang, RM Goto, PS Wakenell and RI Taylor Jr

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P28

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma

Authors: S Montaner, R Chaisuparat, J Hu and BC Jham

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P29

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon

Authors: P Ndom, ZK Bissek, C Takouchop, MT Obama, G Bengono and RW Ryder

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P30

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium

Authors: P Nowicki, A Hoover, K De Geest, M Goodheart, M Lace, T Haugen, L Turek, G Strand, A Bossler, A Klingelhutz and J Lee

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P31

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Colon adenocarcinoma in HIV infected patients

Authors: C Chapman, D Aboulafia, BJ Dezube and L Pantanowitz

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P32

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion

Authors: L Pantanowitz, K Früh, D Aboulafia, S Marconi and BJ Dezube

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P33

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
HIV-associated bladder cancer: diagnosis and management

Authors: L Pantanowitz, EM Gaughan, BJ Dezube, M Bower and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P34

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus

Authors: S Sakakibara and G Tosato

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P35

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Human herpesvirus 8 K1-derived peptides disrupt the inhibitory FAS-K1 complex and restore FAS receptor-mediated apoptosis

Authors: F Samaniego, Z Berkova, H Maeng, S Wang and J Wise

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P36

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Kaposi's sarcoma human herpesvirus K1 interferes with FAS-mediated apoptosis and stimulates clonal growth and lymphoid hyperplasia

Authors: F Samaniego, Z Berkova, H Maeng, S Wang and J Wise

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P37

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Initial experience of an anal dysplasia clinic for HIV-infected men in Seattle, WA

Authors: D Aboulafia and L Siekas

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P38

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice

Authors: S-H Sin, FD Fakhari and DP Dittmer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P39

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Cervical and anal HPV infection and dysplasia in HIV-infected women

Authors: EA Stier, R Tandon, AS Baranoski, F Huang and O Vragrovic

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P40

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770

Authors: TS Uldrick, A Mosam, F Shaik, G Friedland, D Skadden, JP Jordaan, J Aboobaker and HM Coovadia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P41

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)

Authors: TS Uldrick, A Mosam, H Carrara, F Shaik, A Berkman and HM Coovadia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P42

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV

Authors: P Unemori, P Hunt, K Leslie, E Sinclair, S Deeks, J Martin and T Maurer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P43

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
The spectrum of HIV-associated cancers in a South African black population: results from a case-control study, 1995–2004

Authors: MI Urban, L Stein, D O'Connell, X Qin Yu, R Newton, P Ruff, B Donde, M Hale, M Patel, P Kellett and F Sitas

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P44

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia

Authors: P Velasco, L Dutcher, DA Davis and R Yarchoan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P45

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Geographic variation of the prevalence of Kaposi's sarcoma-associated herpesvirus and risk factors for transmission in women from 8 countries in four continents

Authors: D Whitby, S De Sanjose, G Mbisa, S Perez, S Sukvirach, N Trong Hieu, HR Shin, ANH PTH, JO Thomas, E Lazcano, E Matos, R Herrero, N Muňoz and S Franceschi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P46

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus

Authors: Y Zhang, D Patel and S Fan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P47

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF
Activation of RSK and ERK MAPK kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus

Authors: F Zhu, E Kuang and F Wu

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P48

Content type: Poster presentation Published on: 17 June 2009
- View Full Text
- View PDF

Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Meeting abstracts

MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival

Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma

Genetic resistance to GAHV-2 induced lymphoma in the chicken model

AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma

Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon

Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium

Colon adenocarcinoma in HIV infected patients

Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion

HIV-associated bladder cancer: diagnosis and management

Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus

Human herpesvirus 8 K1-derived peptides disrupt the inhibitory FAS-K1 complex and restore FAS receptor-mediated apoptosis

Kaposi's sarcoma human herpesvirus K1 interferes with FAS-mediated apoptosis and stimulates clonal growth and lymphoid hyperplasia

Initial experience of an anal dysplasia clinic for HIV-infected men in Seattle, WA

Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice

Cervical and anal HPV infection and dysplasia in HIV-infected women

Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770

Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)

CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV

The spectrum of HIV-associated cancers in a South African black population: results from a case-control study, 1995–2004

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia

Geographic variation of the prevalence of Kaposi's sarcoma-associated herpesvirus and risk factors for transmission in women from 8 countries in four continents

Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus

Activation of RSK and ERK MAPK kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus

Affiliated with

Follow

Annual Journal Metrics

Infectious Agents and Cancer

Contact us